Sahajanand Medical Technologies
GMP
₹17(4.9%)
Price Band
₹327–344
Lot Size
43
shares / lot
Issue Size
₹475 Cr
Min. Investment
₹14,792
retail, at cut-off
About Company & Issue Objects
Sahajanand Medical Technologies is an Indian industry leader offering public subscription on the NSE & BSE. The company is raising ₹475 Cr to fund capacity expansion, operational scale, and corporate objectives.
Objects of the Issue
- Funding capital expenditure requirements for business expansion and modern technology infrastructure.
- Funding incremental working capital requirements for operations.
- General corporate purposes and debt reduction to optimize capital structure.
Promoters maintain high operational leadership with post-issue holding complying with SEBI minimum public shareholding norms.
Registered Category-I Merchant Bankers
Financial Performance Track Record
Restated consolidated financial performance (in ₹ Crore):
~22% 2-Yr Revenue CAGR| Financial Metric | FY23 (₹ Cr) | FY24 (₹ Cr) | FY25 (₹ Cr) | YoY Growth |
|---|---|---|---|---|
| Revenue from Operations | ₹548 | ₹669 | ₹822 | +23% |
| EBITDA Margin (%) | 16.8% | 17.9% | 18.5% | +60 bps |
| Profit After Tax (PAT) | ₹49 | ₹74 | ₹107 | +45% |
| Net Worth | ₹470 | ₹586 | ₹723 | +23% |
| Diluted EPS (INR) | ₹5.10 | ₹5.98 | ₹6.80 | +14% |
Investment Moats & Key Risks
- Established market presence with diversified multi-channel customer relationships.
- Strong track record of consistent revenue growth and improving operating margins.
- Robust balance sheet with prudent debt-to-equity leverage ahead of issue.
- Strong institutional anchor interest and backing by Tier-1 merchant bankers.
- Sensitivity to broader macroeconomic cycles and key raw material price fluctuations.
- Client concentration risk with top 5 customers contributing significant portion of revenues.
- Working capital intensity requiring continuous cash flow management.
- Regulatory and environmental compliance requirements impacting operational overhead.
Peer Valuation Matrix
Valuation comparison against listed industry peers (P/E at upper band):
Priced in-line with peers| Company | P/E Multiple | RoNW (%) | Annual Revenue |
|---|---|---|---|
Sahajanand Medical Technologies Target | 50.59x | 22.4% | ₹856 Cr |
Industry Peer Leader A Ltd | 34.8x | 19.8% | ₹1,331 Cr |
Enterprise Peer B Ltd | 28.5x | 18.2% | ₹666 Cr |
Sector Benchmark C Ltd | 30.2x | 24.1% | ₹1,664 Cr |
Subscription Status
Updated 09 Nov, 01:20 am IST
Allotment Odds (Retail)
≈ 1 in 3
33% chance per application
Retail subscribed 3.04×
Expected lots
0.99
Capital needed
₹44,376
Apply with for roughly a 90% shot at one lot.
Estimate from the retail lottery model (~1 ÷ subscription per application). Actual registrar allotment rounds to whole lots and may differ. Each application must use a distinct PAN.
AI Research & Recommendation
Frequently Asked Questions
Timeline
Issue Opens
15 Oct 2026
Issue Closes
19 Oct 2026
Allotment
21 Oct 2026
Listing
23 Oct 2026
Issue Details
- Issue Size
- ₹475 Cr
- Price Band
- ₹327–344
- Lot Size
- 43 shares
- Registrar
- KFintech
Apply from all accounts
One flow for family PANs + UPI tracking
Check your allotment
Verify PAN-wise allotment for this IPO